Trading & Technical Analysis

Technology is reshaping modern medicine

But ethical and economic challenges could limit the benefits medtech brings to healthcare. The Nobel Prize in Medicine 2019 was awarded to three men for “their discoveries of how cells sense and adapt to oxygen availability”. The Nobel Prize in Medicine 2018 was given to two men “for their discovery of cancer therapy by inhibition…

Investor Signposts: Week Beginning January 20 2020

Australia: Quiet week ahead • The fourth week of the year looks to be a quiet one for economic data, both in Australia and the US. In Australia consumer sentiment and employment data dominate the list of scheduled releases. • The week kicks off on Tuesday when the Commonwealth Bank releases the December Household spending…

Gold buying surges can be precarious

Gold dramatically surged to major new secular highs this past week, fueled by stunning geopolitical news. The US assassinated Iran’s top general, so Iran fired ballistic missiles at military bases in Iraq used by the US. That naturally ramped gold bullishness, spawning all kinds of predictions for much-higher prices. But geopolitically-driven gold spikes never last…

Can these Worst Performers of 2019 Make a Comeback in 2020?

Regardless of investing philosophy, retail investors who pick their own stocks have much to consider reviewing the share price performance of annual “winners and losers” Growth investors who believe in buying high and selling higher gravitate towards the year’s best performers. Momentum and value investors can consider select losers capable of a comeback or a…

Beware The Downside Of Gold Stocks

The gold miners’ stocks have largely been consolidating high following last summer’s powerful upleg. That resilience has left sentiment relatively bullish, with traders mostly expecting this sector to soon start surging again. But the jury is still out on whether gold stocks will be lucky enough to evade a bigger correction. Major downside risks still…

The Worst Is Over For Oil Markets

Some analysts see the world dodging a recession next year, which provides some upward room for oil prices. Last week, the IEA warned last week that “the hefty supply cushion” building up in the first half of 2020 will cause OPEC+ problems as the group tries to balance the oil market. Part of the reason…

ASX Medical Marijuana Stocks – Buy, Wait and See, or Stay Away

On 5 December of 1996 the Chairman of the US Federal Reserve, Alan Greenspan, coined a phrase that should be etched in the psyche of all retail investors – irrational exuberance. It was the time of the dot.com stocks qualifying as “next big thing” stock market entries, sometimes backed by little more than a paper…

Big US Stocks’ Q3’ 2019 Fundamentals

The US stock markets have surged to all-time-record highs, fueled by extreme Fed easing. It jawboned about rate cutting, slashed rates, and birthed a new large-scale Treasury monetization campaign! All this has left traders hyper-complacent, assuming the upside will continue indefinitely. But are these lofty stock levels fundamentally-justified? The big US stocks’ just-reported Q3’19 results…

Equity market vigilantes

If I say the word “vigilante”, what image springs to mind? For many years it would have been Sylvester Stallone as Rambo. He’s the muscled-up army veteran using his skills to fight corruption and oppressive outcomes. However, it’s fair to say the action hero industry is evolving, and these days we’re increasingly seeing female characters…

Graphene Additives Making their Mark

Some investors lose patience waiting for “next big thing” breakthroughs. The time between concept and commercialisation to generate substantial returns on stock market investments in companies involved with the reportedly revolutionary capabilities of the breakthrough and seem an eternity. Others realize the path from concept to profit can be long and torturous. Such has been…